EVALUATION OF THE POTENTIAL ASSOCIATED FACTORS CONTRIBUTING TO VARIOUS SIDE EFFECTS OF COVID-19 VACCINES IN BANGLADESH
DOI:
https://doi.org/10.22159/ijap.2023v15i6.49298Keywords:
Covid-19 vaccine, Vaccine’s side effects, Comorbidity, Vaccine comparison, Public healthAbstract
Objective: Due to questions about the safety and possible side effects of COVID-19 vaccines, initially, most individuals with chronic comorbid conditions showed unwillingness to vaccination. Though COVID-19 vaccines were found safe in clinical trials, real-world results still need to be explored to generate and further analyze the safety and efficacy profile of these vaccines. Our study aimed to evaluate and associate the various side effects of COVID-19 vaccines at different covariate levels along with comorbid conditions.
Methods: This cross-sectional study aimed to evaluate the side effects of COVID-19 vaccines in Bangladesh using data collected from a sample of vaccinated individuals through a structured questionnaire. The data were analyzed using descriptive statistics, bivariate analysis with a chi-square test, and multiple logistic regression model to identify the frequency, severity, and duration of side effects, as well as the associations between side effects and potential predictors. Our study investigated the side effects of four prominent approved COVID-19 vaccines in Bangladesh.
Results: The findings revealed that Sinopharm was the most administered vaccine, accounting for 55% of the respondents. The majority of participants (38%) reported experiencing mild side effects, such as pain at the injection site, fatigue, and headache, while only 13% required hospitalization due to severe side effects. Significant associations were observed between vaccine type and variables such as gender, age group, concomitant health complications, prior COVID-19 history, physician's recommendation, and adverse consequences. Logistic regression analysis identified significant associations between the presence of side effects and variables such as concomitant health complications (OR=3.2 p-value: 0.011) and concomitant medications (OR=0.38, p-value: 0.039).
Conclusion: These results provide valuable insights to help guide vaccination strategies and ensure vaccine safety in Bangladesh. Further investigation into these aspects in larger and more diverse groups is necessary, taking longitudinal follow-up and the objective evaluation of side effects into consideration.
Downloads
References
Pal M, Berhanu G, Desalegn C, Kandi V. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update. Cureus. 2020 Mar 26;12(3):e7423. doi: 10.7759/cureus.7423, PMID 32337143.
Zheng J. SARS-CoV-2: an emerging coronavirus that causes a global threat. Int J Biol Sci. 2020;16(10):1678-85. doi: 10.7150/ijbs.45053, PMID 32226285.
Hu B, Guo H, Zhou P. Microbiology ZS-NR, 2021 undefined. Characteristics of SARS-CoV-2 and COVID-19; 2021. Available from: https://www.nature.com/articles/s41579-020-00459-7.
Yashavantha Rao HC, Jayabaskaran C. The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients. J Med Virol. 2020 Jul 1;92(7):786-90. doi: 10.1002/jmv.25918, PMID 32320066.
Symptoms of COVID-19. CDC. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
Dhar Chowdhury S, Oommen AM. Epidemiology of COVID-19. Journal of Digestive Endoscopy. 2020;11(1):3-7. doi: 10.1055/s-0040-1712187.
Kadam H, Kaphare G, Avhad R, Aher P, Gade N, Bajait M. Long-term immunological consequences of COVID-19 on health. Int J App Pharm. 2022 Jan 7;14(1):42-9. doi: 10.22159/ijap.2022v14i1.42311.
Attia YA, El-Saadony MT, Swelum AA, Qattan SYA, Al-qurashi AD, Asiry KA. COVID-19: pathogenesis, advances in treatment and vaccine development and environmental impact-an- an updated review. Environ Sci Pollut Res Int. 2021 May 1;28(18):22241-64. doi: 10.1007/s11356-021-13018-1, PMID 33733422.
Yang L, Tian D, Liu W. Strategies for vaccine development of COVID-19. Sheng Wu Gong Cheng Xue Bao. 2020 Apr 25;36(4):593-604. doi: 10.13345/j.cjb.200094, PMID 32347054.
Larsen JR, Martin MR, Martin JD, Hicks JB, Kuhn P. Modeling the onset of symptoms of COVID-19: effects of SARS-CoV-2 variant. PLOS Comput Biol. 2021 Dec 1;17(12):e1009629. doi: 10.1371/journal.pcbi.1009629, PMID 34914688.
Antiviral therapy summary recommendations | COVID-19 treatment guidelines. Available from: https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/summary-recommendations. [Last accessed on 27 Oct 2022]
Qadrie ZL, Wani SUD, Gautam SP, Khan MKA. Outbreak, epidemiology, therapeutics and prevention of coronavirus disease-2019: a review. Int J Curr Pharm Sci 2020;12(5):1-4. doi: 10.22159/ijcpr.2020v12i5.39755.
He Q, Mao Q, Zhang J, Bian L, Gao F, Wang J. COVID-19 vaccines: current understanding on immunogenicity, safety, and further considerations. Front Immunol. 2021 Apr 12;12:669339. doi: 10.3389/fimmu.2021.669339, PMID 33912196.
How many types of COVID-19 vaccines are there?–COVID19 Vaccine Tracker. Available from: https://covid19.trackvaccinestrackvaccines.org/vaccine-types [Last accessed on 27 Jun 2023]
COVID-19. Available from: http://dashboard.dghs.gov.bd/webportal/pages/covid19-vaccination-update.php. [Last accessed on 27 Jun 2023]
Omeish H, Najadat A, Al-Azzam S, Tarabin N, Abu Hameed A, Al-Gallab N. Reported COVID-19 vaccines side effects among Jordanian population: a cross-sectional study. Hum Vaccin Immunother. 2022;18(1):1981086. doi: 10.1080/21645515.2021.1981086, PMID 34614383.
Possible side effects after getting a COVID-19 vaccine. CDC. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html.
Ganesan S, Al Ketbi L. NAK-F in public. Undefined. Vaccine side effects following COVID-19 vaccination among the residents of the UAE-an observational study. 2022. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120526. [Last accessed on 27 Oct 2022]
Abedin M, Islam MA, Rahman FN, Reza HM, Hossain MZ, Hossain MA. Willingness to vaccinate against COVID-19 among Bangladeshi adults: understanding the strategies to optimize vaccination coverage. Plos One. 2021;16(4):e0250495. doi: 10.1371/journal.pone.0250495, PMID 33905442.
Kim J, Marks F. Medicine JCN. Looking beyond COVID; 19 vaccine phase 3 trials; 2021. Available from: https://www.nature.com/articles/s41591-021-01230-y.
Geneva: WHO. Coronavirus Disease (COVID-19) Dashboard with vaccination Data | WHO coronavirus (COVID-19) dashboard with vaccination data. Available from: https://covid19.who.int/region/searo/country/bd. [Last accessed on 27 Oct 2022]
Geneva: WHO. Coronavirus disease (COVID-19) dashboard with vaccination data | WHO coronavirus (COVID-19) Dashboard with vaccination data. Available from: https://covid19.who.int/region/searo/country/bd. [Last accessed on 27 Jun 2023]
Medeiros KS, Costa APF, Sarmento ACA, Freitas CL, Gonçalves AK. Side effects of COVID-19 vaccines: a systematic review and meta-analysis protocol of randomised trials. BMJ Open. 2022 Feb 24;12(2):e050278. doi: 10.1136/bmjopen-2021-050278, PMID 35210336.
Viswanath KH, Basra SS, Chourey N, Kumar DS. Coronavirus disease 2019 vaccination drive: the perceptions and acceptance of vaccination among health care workers. Asian J Pharm Clin Res. 2021 Jun 7;14:177–81. Available from: https://journals.innovareacademics.in/index.php/ajpcr/article/view/41971.
Iguacel I, Maldonado AL, Ruiz Cabello AL, Casaus M, Moreno LA, Martinez Jarreta B. Association between COVID-19 vaccine side effects and body mass index in Spain. Vaccines. 2021 Nov 1;9(11). doi: 10.3390/vaccines9111321, PMID 34835252.
Elnaem MH, Mohd Taufek NH, Ab Rahman NS, Mohd Nazar NI, Zin CS, Nuffer W. COVID-19 vaccination attitudes, perceptions, and side effect experiences in Malaysia: do age, gender, and vaccine type matter? Vaccines. 2021 Oct 1;9(10). doi: 10.3390/vaccines9101156, PMID 34696264.
Ganesan S, Al Ketbi LMB, Al Kaabi N, Al Mansoori M, Al Maskari NN, Al Shamsi MS. Vaccine side effects following COVID-19 vaccination among the residents of the UAE-an observational study. Front Public Health. 2022 May 6;10:876336. doi: 10.3389/fpubh.2022.876336, PMID 35602146.
Bhujade R, Yadav K, Kumar J, Pukar M, Bhatt R, Baghel AS. Cross-sectional survey to assess the beneficiaries experience regarding COVID-19 vaccination in vaccinated candidates in a tribal district of rajasthan–emigh prospective. Asian J Pharm Clin Res. 2023 Jun 7:82-5. doi: 10.22159/ajpcr.2023.v16i6.47290.
Beatty AL, Peyser ND, Butcher XE, Cocohoba JM, Lin F, Olgin JE. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw Open. 2021 Dec 22;4(12):e2140364. doi: 10.1001/jamanetworkopen.2021.40364, PMID 34935921.
Omeish H, Najadat A, Al-Azzam S, Tarabin N, Abu Hameed A, Al-Gallab N. Reported COVID-19 vaccines side effects among Jordanian population: a cross-sectional study. Hum Vaccin Immunother. 2022;18(1):1981086. doi: 10.1080/21645515.2021.1981086, PMID 34614383.
Published
How to Cite
Issue
Section
Copyright (c) 2023 SAMIHA TAMANNA, RUPALI GHOSH, SAKIB REZA, SOJIBUL ISLAM, NOOR MUHAMMAD KHAN
This work is licensed under a Creative Commons Attribution 4.0 International License.
